TScan Therapeutics, Inc. (TCRX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $10.32M | +266.7% |
| 2024 | $2.82M | -86.6% |
| 2023 | $21.05M | +55.5% |
| 2022 | $13.54M | +33.5% |
| 2021 | $10.14M | +834.7% |
| 2020 | $1.08M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $10.32M | +266.7% |
| 2024 | $2.82M | -86.6% |
| 2023 | $21.05M | +55.5% |
| 2022 | $13.54M | +33.5% |
| 2021 | $10.14M | +834.7% |
| 2020 | $1.08M | — |